A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: Consistent chromosomal abnormalities and temporary C-MYC gene amplification

Cancer Genetics and Cytogenetics

Volumn 100, Issue 1, 1998, Pages 21-24

  Yoshida, Hitoshi ^a   Kondo, Makoto ^b   Ichihashi, Takuji ^a   Hashimoto, Naoya ^c   Inazawa, Joji ^c   Ohno, Ryuzo ^d   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 14; CYTOGENETICS; DRUG EFFECT; FEMALE; GENE DELETION; HUMAN; KARYOTYPE 46,XX; LEUKEMOGENESIS; ONCOGENE C MYC; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

PISUM SATIVUM; PURPURA;

EID: 0031983862     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00017-4     Document Type: Article

References (14)

1. 1. Foucar K, McKenna RW, Bloomfield CD, Bowers TK, Brunning RD (1979): Therapy-related leukemia: A panmyelosis, Cancer 43:1285-1296.
2. 2. Kantarjian HM, Keating MJ, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ (1986): Therapy-related leukemia and myelodysplastic syndrome: Clinical, cytogenetic, and prognostic features. J Clin Oncol 4:1748-1757.
3. 3. Michels SD, McKenna RW, Arthur DC, Brunning RD (1985): Therapy-related acute myeloid leukemia and myelodysplastic syndrome: A clinical and morphologic study of 65 cases. Blood 65:1364-1372.
4. 4. Le Beau MM. Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD (1986): Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 4:325-345.
5. 5. Levine EG, Bloomfield CD (1992): Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure, Semin Oncol 19:47-84.
6. 6. Higuchi T, Okada S, Mori H, Niikura H, Omine M, Terada H (1995): Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent. Cancer 75:471-477.
7. 7. Naoe T, Akao Y, Yamada K, Utsumi KR, Koike K, Shamoto M, Koie K, Kurosawa Y, Kato K, Abe M, Shiku H (1988): Cytogenetic characterization of a T-cell line, ATN-1, derived from adult T-cell leukemia cells. Cancer Genet Cytogenet 34:77-88.
8. 8. Ariyama T, Inazawa J, Uemura Y, Kakazu N, Maekawa T, Urase F, Irimajiri K, Horiuchi A, Nakamura Y, Abe T (1995): Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia. Cancer Genet Cytogenet 81:20-23.
9. 9. Nowell P, Finan J, Dalla-Favera R, Gallo RC, ar-Rushdi A, Romanczuk H, Selden JR, Emmanuel BS, Rovera G, Croce CM (1983): Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line. Nature 306:494-497.
10. 10. The Third International Workshop on Chromosomes in Leukemia (1981): Reports on essential thrombocythemia. Cancer Genet Cytogenet 4:138-142.
11. 11. Sedlacek SM, Curtis JL, Weintraub J, Levin J (1986): Essential thrombocythemia and leukemic transformation. Medicine 65:353-364.
12. 12. Sessarego M, Defferrari R, Dejana AM, Rebuttato AM, Fugazza G, Salvidio E, Ajmar F (1989): Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study. Cancer Genet Cytogenet 43:57-65.
13. 13. Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersboll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC, Specht L, Østerfind K. (1993): Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 7:1975-1986.
14. 14. Rowley JD, Le Beau MM (1989): Cytogenetic and molecular analysis of therapy-related leukemia. Ann NY Acad Sci 567:130-140.